Indexed in Journament

JNCI Journal of the National Cancer Institute

Oxford University Press· EN

Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
51.5 / 100
Journament Score
Average
Ranked #137 of 29,299 scored journals (34,035 indexed)
407 Articles
Scores higher than 99.5% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name JNCI Journal of the National Cancer Institute
Abbreviated Name JNCI Journal of the National Cancer Institute

Quality Profile

4 of 12 dimensions measured
Engagement 30.8
Timeliness 100.0
Community Impact 13.6
Content Distribution 61.3
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

8 of the 12 dimensions could not be measured for this journal. They are left out entirely rather than plotted as zero, and with 4 dimensions measured there is not enough of a profile to draw as a shape.

Show the numbers
Dimension This journal Corpus average
Engagement 30.8 30.6
Accessibility — 23.3
Timeliness 100.0 3.0
Diversity — 25.9
Innovation — 24.1
Community Impact 13.6 6.7
Content Distribution 61.3 89.8
Content Quality — 55.1
Ethics & Transparency — 40.5
Editorial Standards — 33.0
Publication Regularity — 52.9
Geographic Reach — 30.4

Publications Per Year

Articles (407)

1994
Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands
D E Goldgar, Douglas F. Easton, Lisa Cannon‐Albright, M.H. Skolnick
123 views DOI Abstract
2007
Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab
Frank A. Scappaticci, Jamey Skillings, Scott N. Holden, Hans Peter Gerber, Kathy D. Miller, Fairooz F. Kabbinavar, Emily K. Bergsland, Jenny Ngai, Eric Holmgren, Jia Wang, H. Hurwitz
90 views DOI Abstract
2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanoma
Sophie E Orme, Serigne N Lo, Robyn P Saw, Kerwin F Shannon, AndrewJ Spillane, Jonathan R. Stretch, Sydney Ch’ng, Omgo E Nieweg, John F Thompson, Michelle M. Dugan, Danielle K. DePalo, Helana Ghali, Jonathan S Zager, Martin Heaton, Andrew Snelling, Iva Johansson, Roger Olofsson Bagge, Carolyn Nessim, Marc Moncrieff
82 views DOI Abstract
2014
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton, Mairéad G. McNamara, Boštjan Šeruga, Francisco Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz‐Amit, Guru Sonpavde, Jennifer J. Knox, Ben Tran, Ian F. Tannock, Eitan Amir
81 views DOI Abstract
2007
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
Maurizio Scaltriti, Federico Rojo, Alberto Ocaña, Judit Anido, Marta Guzmán, Javier Cortés, Serena Di Cosimo, Xavier Matías‐Guiu, Santiago Ramón y Cajal, Joaquı́n Arribas, José Baselga
69 views DOI Abstract
1989
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
M. H. Gail, Louise A. Brinton, David P. Byar, Donald K. Corle, S. B. Green, C. Schairer, John J. Mulvihill
69 views DOI Abstract
2004
Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer
Jianzhong Shou, Suleiman Massarweh, C. K. Osborne, A. E. Wakeling, Simak Ali, Helen A. Weiss, Rachel Schiff
68 views DOI Abstract
2017
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Ahmedin Jemal, Elizabeth Ward, Christopher J. Johnson, Kathleen A. Cronin, Jiemin Ma, A. Blythe Ryerson, Angela B. Mariotto, Andrew Lake, Reda Wilson, Recinda Sherman, Robert N. Anderson, S. Jane Henley, Betsy Kohler, Lynne Penberthy, Eric J. Feuer, Hannah K. Weir
63 views DOI Abstract
2017
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yibing Yang, Xinya Gao, Maolei Zhang, Sheng Yan, Chengjun Sun, Feizhe Xiao, Nunu Huang, Xuesong Yang, Kun Zhao, Huangkai Zhou, Suyun Huang, Bo Xie, Nu Zhang
62 views DOI Abstract
1996
Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
Gilbert S. Omenn, Gary E. Goodman, Mark Thornquist, John R. Balmes, Mark R. Cullen, Andrew Glass, James P. Keogh, Frank L. Meyskens, Barbara Valanis, J. H. Williams, Scott Barnhart, Martin G. Cherniack, Carl A. Brodkin, Samuel P. Hammar
61 views DOI Abstract
2026
The impact of the changing landscape of NIH funding for the cancer prevention and control research enterprise
Sharon L. Manne, Anita Yeomans Kinney, Cheryl L. Thompson, Victoria Lee Champion, Marian Fitzgibbon, Anne Hudson Blaes, Angela J. Fong, Raquel Kelly Kohler, Kelly A. Hirko, Melissa Andrea Simon, William A. Calo, Amy Trentham‐Dietz, Marquita Lewis, Chris Rini, Electra D. Paskett
1 views DOI Abstract
2026
Impact of psychosocial interventions on cancer survival: an updated meta-analysis
Victoria McCarvell, Emma McCurdy-Franks, Saverio Caini, Chiara Doccioli, Gary Rodin, Cassidy MacNaughton, Shirley Tse, Edward Chow, Henry C. Y. Wong
1 views DOI Abstract
2026
Antibody drug conjugate efficacy: are we measuring the right treatment effect?
Jia Liu, Hao‐Wen Sim
2 views DOI
2026
Subgroup variations in benefit from telehealth palliative care for advanced lung cancer
Kathryn Elizabeth Post, Chardria Trotter, Amy M Munankarmi, Phalaen Chang, Toby Christopher Campbell, Michael W. Rabow, Laura C. Hanson, Lori Ann Spoozak, Carl Grey, Leslie J. Blackhall, Elaine Y. Chen, Ramona L. Rhodes, Amelia M. Cullinan, Nora Horick, Dustin John Rabideau, Areej R El-Jawahri, Jennifer S. Temel, Joseph A. Greer
7 views DOI Abstract
2026
Statewide surveillance of colorectal cancer screening using geospatial and Multi-Payer claims data
Katherine Elizabeth Reeder-Hayes, Bradford E. Jackson, Jennifer Lund, Tzy‐Mey Kuo, Arrianna Marie Planey, Anisha Ganguly, Brian J. Reich, Daniel S. Reuland, Stephanie B. Wheeler, Christopher D. Baggett
6 views DOI Abstract
2026
Carcinogen exposure, TP53 , and clonal selection in the oral cavity
Andrew Gregory Sikora, Jennifer L. Anderson, Xiao Zhao, Yu Leo Lei
8 views DOI
2026
Tailoring adjuvant endocrine therapy in patients with estrogen receptor-low breast cancer
Julian David Etessami, Giuseppe Curigliano, Carmine Valenza
9 views DOI
2026
Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorship
Maroun Bou Zerdan, Jad Assi, Youssef Bouferraa, Jana Abu Faraj, Nadeem Bilani, Brianna Brammer, Elias A Castro, Christophe Abi Zeid Daou, William A. Stokes, Soumon F. Rudra, James E. Bates, Anthea L. Hammond, Dong M Shin, Yong Teng, Nicole Cherie Schmitt, Nabil F. Saba
9 views DOI Abstract
2026
RE: Endocrine Therapy in Early-stage Estrogen Receptor-Low Breast Cancer: A Systematic Review and Meta-Analysis
Yakup Ergün
9 views DOI Abstract
2026
Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis
Samuel Jacob Margolis, Tahmineh R. Kalbasi, Yuliya Zektser, Arman M. Niknafs, Joyce Cui, Marla D. Lipsyc-Sharf, Alexis Ann LeVee, Hope S. Rugo, Aditya Bardia, Mina S. Sedrak
12 views DOI Abstract
Journament Score
51.5/100 · Average
Ranked #137 of 29,299 scored
(34,035 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

51.5/100

Tier: Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.8/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

Not yet measured

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

Not yet measured

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

Not yet measured

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

13.6/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

100.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

61.3/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.